Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

70
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
70
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

87
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
87
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

98
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
98
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

76
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
76
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

125
Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
125
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

148
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
148

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Eastern Spanish experience with nivolumab in metastatic renal cell carcinoma.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2020
Same author

Altered CD4<sup>+</sup> T cell immunity in nurses occupationally exposed to viral pathogens.

Clinical and experimental immunology·2018
Same author

Treatment of 213 Patients with Symptomatic Tarlov Cysts by CT-Guided Percutaneous Injection of Fibrin Sealant.

AJNR. American journal of neuroradiology·2015
Same author

Outcomes of Percutaneous Management of Anastomotic Ureteral Strictures in Renal Transplantation: Chronic Nephroureteral Stent Placement with and without Balloon Dilatation.

Cardiovascular and interventional radiology·2014
Same author

Primary antiphospholipid syndrome in monozygotic twins.

Lupus·2012
Same author

Characterization of CMPO and its radiolysis products by direct infusion ESI-MS.

Talanta·2012

Related Experiment Video

Updated: Oct 7, 2025

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.5K

COVID-19 in Kidney Transplantation.

P K Garcia-Padilla1, G Elías2, P Paola2

  • 1Nephrology. Department of Internal Medicine. Hospital Universitario San Ignacio, Pontificia Universidad Javeriana, Bogota, Colombia.

International Journal of Organ Transplantation Medicine
|January 6, 2022
PubMed
Summary

Kidney transplant recipients with COVID-19 infection can experience varied symptoms, including gastrointestinal issues and pneumonia. Prompt treatment led to positive outcomes in two reported cases, highlighting the importance of timely intervention for immunocompromised patients.

Keywords:
COVID-19CoronavirusKidney transplantPneumonitis

More Related Videos

TBase - an Integrated Electronic Health Record and Research Database for Kidney Transplant Recipients
09:00

TBase - an Integrated Electronic Health Record and Research Database for Kidney Transplant Recipients

Published on: April 13, 2021

4.8K
Robot-Assisted Kidney Transplantation
07:30

Robot-Assisted Kidney Transplantation

Published on: July 19, 2021

3.8K

Related Experiment Videos

Last Updated: Oct 7, 2025

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.5K
TBase - an Integrated Electronic Health Record and Research Database for Kidney Transplant Recipients
09:00

TBase - an Integrated Electronic Health Record and Research Database for Kidney Transplant Recipients

Published on: April 13, 2021

4.8K
Robot-Assisted Kidney Transplantation
07:30

Robot-Assisted Kidney Transplantation

Published on: July 19, 2021

3.8K

Area of Science:

  • Nephrology
  • Infectious Diseases
  • Immunology

Background:

  • COVID-19 poses increased mortality risks for older adults with comorbidities like diabetes and hypertension.
  • Immunocompromised individuals, including kidney transplant recipients, are particularly vulnerable to severe COVID-19 outcomes.
  • The interaction between SARS-CoV-2 infection, immunosuppression, and immunosuppressant medications requires careful consideration.

Observation:

  • Two kidney transplant recipients diagnosed with COVID-19 infection were analyzed.
  • The first patient exhibited gastrointestinal symptoms progressing to multilobar pneumonia.
  • The second patient presented with fever, gastrointestinal, urinary symptoms, and a dry cough.

Findings:

  • Both kidney transplant recipients with COVID-19 infection demonstrated varied clinical presentations.
  • Despite complex health statuses, both patients responded positively to therapeutic interventions.
  • Early recognition and management are crucial for favorable outcomes in this patient cohort.

Implications:

  • These cases underscore the need for vigilant monitoring of kidney transplant recipients for COVID-19.
  • Effective treatment strategies can lead to successful recovery in immunocompromised patients.
  • Further research into COVID-19 management in transplant populations is warranted to optimize care protocols.